Cargando…
Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and one of the leading causes of cancer-related death worldwide. HCC is highly heterogeneous, both within the tumor and among individuals, which is closely related to the HCC surveillance, diagnosis, prognosis, and treatment resp...
Autores principales: | Pan, Yasi, Chen, Huarong, Yu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762241/ https://www.ncbi.nlm.nih.gov/pubmed/33297335 http://dx.doi.org/10.3390/biomedicines8120576 |
Ejemplares similares
-
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
por: Okusaka, Takuji, et al.
Publicado: (2018) -
Current status and future perspectives of radiomics in hepatocellular carcinoma
por: Miranda, Joao, et al.
Publicado: (2023) -
Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
por: Hsu, Chih-Hung, et al.
Publicado: (2014) -
Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
por: Mandlik, Deepa S, et al.
Publicado: (2023) -
Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma
por: Siak, Pui Yan, et al.
Publicado: (2021)